SCA
CSII

Snowden Capital Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Snowden Capital Advisors’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-39
Closed – – 2186
2021
Q4 		$0 Buy
+39
New +$1.04K ﹤0.01% 2191

Other funds holding CSII

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Snowden Capital Advisors's CSII Position: Q1 2022 in Review

Snowden Capital Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2022, closing a stake of 39 shares.

Snowden Capital Advisors first reported a position in CSII in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 174 funds tracked by Wall St. Rank hold CSII as of Q1 2022.

  • Snowden Capital Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q1 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 39 Cardiovascular Systems, Inc. shares in Q1 2022.
  • Snowden Capital Advisors first reported a position in Cardiovascular Systems, Inc. in Q4 2021 and held it in 1 quarter.
  • Snowden Capital Advisors's Cardiovascular Systems, Inc. position peaked at $0 in Q4 2021.
  • 174 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.